There has been some discussion in our institution about re-instituting a weekly order "rewrite" in the EHR similar to what was done back when we were on paper.

The thought that some have is that this will eliminate some of the errors we are seeing in relation to timing and meds "falling off the MAR."

I've been arguing against this practice as I think it will increase other errors and increase workload for all (physicians, nurses and pharmacists).

Can you provide me your pros/cons for this practice as well as any supporting literature?

Our BCMA compliance data revealed that we do not regularly scan the "Bolus from Bag" orders prior to administration (the order prompts the RN to scan the continuous infusion bag when attempting to document a given dose). Discussions with nursing have revealed that it is not always feasible to scan the bolus from bag prior to giving the dose (bolused through the smart pump as bolus from bag) due to the emergent needs of the patient.

What practices do your Covid vaccine sites have in place to separate Pfizer and Moderna vaccines from the preparation to administration stage? I did a brief search on here and saw some locations have created separate areas or use different color codes. Any other tips would be great!

Thanks,

Tanvi

Hi all -
On average, how many overrides from the ADMs do you see per month? I would love to see numbers of non controlled vs controlled substances.
Thanks -
Maria Cumpston, PharmD, CPPS
Medication Safety Officer
WVU Medicine

We are about to take the upgrade from our ADC vendor in order to be able to require ISMP's recommended 5 letter minimum. If you have implemented this functionality in your organization, would you be able to share your lessons learned? Please message me if you are willing to share.
Thanks much!

We currently have our pump library setup with an oxytocin induction entry that is for 1-20 milliunits/min and then we have a post-partum entry in which is run at 350 mL/hr. We have lots of 'events' that show up on our pump data involving oxytocin because they do not change over to the post-partum entry and the pump library hits the guardrail. Out smart pump team was wondering what other institutions have built out for their oxytocin and if/how they differentiate between induction and post-partum infusions. Thanks!

For those who do hazardous sterile compounding are you doing in-hood skills validation or do you just do didactic training? Thanks!!

Has anyone had any problems with the prefilled Phytonadione with a Saf-T-Jet needle device? Specifically any concerns with the quality of the device/injuries?
Are there any other brands available?

We are trying to develop a policy and work instruction for how to handle patient's own insulin pumps in a perioperative setting and also for patients that are admitted acutely ill and on an insulin pump at home. I would appreciate any information and/or resources that anyone could provide. Do you have standard instructions for when to adjust or turn pump off prior to surgery/procedures? How and when to transition to intermittent sq insulin for inpatient use? Do you allow the use of patient's home continuous glucose monitoring systems? etc. Thanks in advance!

We are trying to develop a policy and work instruction for how to handle patient's own insulin pumps in a perioperative setting and also for patients that are admitted acutely ill and on an insulin pump at home. I would appreciate any information and/or resources that anyone could provide. Do you have standard instructions for when to adjust or turn pump off prior to surgery/procedures? How and when to transition to intermittent sq insulin for inpatient use? Do you allow the use of patient's home continuous glucose monitoring systems? etc. Thanks in advance!